Current approved therapeutic strategies for IPF and LC treatment.

Comparison of survival probabilities of IPF patients with and

Beatrice ARAMINI, MD PhD

Luca TABBÍ, Medical Doctor, Doctor of Medicine, Polyclinic of Modena, Modena, PM, Department of respiratory disease

Pie chart of modified MRC dyspnea score of chILD in Egyptian patients

Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary

Stefania CERRI, Assistant Professor, MD, PhD, Università degli Studi di Modena e Reggio Emilia, Modena, UNIMO, Department of Medical and Surgical Sciences for Children and Adults

Anna SAMARELLI, Università degli Studi di Modena e Reggio Emilia, Modena, UNIMO, Department of Life Sciences

Gene therapy strategies for idiopathic pulmonary fibrosis: recent

Acute exacerbation of interstitial lung disease in the intensive

Filippo GOZZI, Medical Doctor, Azienda Ospedaliero Universitaria Policlinico Modena, Modena, Pulmonology

Sirt1 antisense long non-coding RNA attenuates pulmonary fibrosis

Pliant Therapeutics Announces Positive Data from the INTEGRIS-IPF

Likelihood ratings for pulmonary nodule presence and confidence ratings

Pie chart of modified MRC dyspnea score of chILD in Egyptian patients